2 completed. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow Anti-Bacterial Agents: new trials by email Literature Review of Anti-Bacterial Agents trials Research Report on Anti-Bacterial Agents
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pharmacokinetics of Meropenem and Aztreonam After Intraperitoneal Administration Via Cycler-therapy in APD Patients Without Peritonitis Meropenem 1000 mg, Aztreonam 2000 mg, automated peritoneal dialysis with following long time dwell - Peritoneal Dialysis Associated Peritonitis, Peritoneal Dialysis (PD) | Phase 2 / Phase 3 | Completed | Karl Landsteiner Insitute for Nephrology and Haemato-Oncology | 12 | 2021-08-31 | 2025-08-11 |
| 7 Days Versus 14 Days of Antibiotics for Neonatal Sepsis 7-day course of antibiotics, 14-day course of antibiotics - Infant, Newborn, Neonatal SEPSIS | Phase 3 | Completed | Indian Council of Medical Research | 261 | 2019-01-01 | 2023-11-02 |
Kidney Failure, Chronic (1) · Neonatal Sepsis (1) · Peritonitis (1) · Recurrence (1) · Sepsis (1)
Disease Attributes (2) · Infections (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Chronic Disease (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Digestive System Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Infant, Newborn, Diseases (1) · Inflammation (1) · Intraabdominal Infections (1) · Kidney Diseases (1) · Male Urogenital Diseases (1) · Peritoneal Diseases (1)
Indian Council of Medical Research (1) · Karl Landsteiner Insitute for Nephrology and Haemato-Oncology (1)
Austria (1) · India (1)
Martin F Wiesholzer, MD (1) · Sourabh Dutta (1)